Growing community of inventors

Rockville, MD, United States of America

Sergei A Tsarev

Average Co-Inventor Count = 3.20

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Sergei A TsarevRobert H Purcell (8 patents)Sergei A TsarevSuzanne U Emerson (8 patents)Sergei A TsarevRobin A Robinson (2 patents)Sergei A TsarevSergei A Tsarev (8 patents)Robert H PurcellRobert H Purcell (77 patents)Suzanne U EmersonSuzanne U Emerson (45 patents)Robin A RobinsonRobin A Robinson (12 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The United States of America, As Represented by the Secretary, Department of Health and Human Services (5 from 3,539 patents)

2. Other (1 from 832,880 patents)

3. The United States of America As Represented by the Secretary of (1 from 2,202 patents)

4. The United States of America As Represented by the Department of Health (1 from 1,217 patents)

5. Novavax, Inc. (1 from 60 patents)


8 patents:

1. 6787145 - Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

2. 6706873 - Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

3. 6696242 - Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

4. 6458562 - Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

5. 6287759 - Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

6. 6207416 - Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

7. 6146643 - Human/simian chimeric hepatitis A virus vaccine

8. 6054567 - Recombinant proteins of a pakistani strain of hepatitis E and their use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…